Skip to main content
. 2014 Apr 1;9(1):156. doi: 10.1186/1556-276X-9-156

Figure 4.

Figure 4

Paclitaxel concentration-time profile in plasma, tumor, liver, and spleen following intravenous administration using nanosuspension formulation.